Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Nader Moazami, MD is a staff cardiothoracic surgeon in the Department of Thoracic and Cardiovascular Surgery, Surgical Director of the Cleveland Clinic Kaufman Center for Heart Failure, and Director of the Cardiac Transplantation and Ventricular Assist Device Therapy Program in the Sydell and Arnold Miller Family Heart & Vascular Institute. His specialty is surgical treatment of heart failure, including heart transplantation and mechanical heart assist devices. He is board-certified in thoracic surgery.
Prior to his appointment to the Cleveland Clinic staff in 2012, Dr. Moazami was surgical director of Cardiac Transplantation and the Mechanical Circulatory Support Program at Abbott Northwestern Hospital, Minneapolis, Minn. His previous positions include surgical director of Cardiac Transplantation and the Total Artificial Heart Program in the Division of Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine. He was also Associate Professor of Surgery at the Washington University School of Medicine from 2001 through 2010.
Dr. Moazami is a graduate of the Columbia University College of Physicians and Surgeons, New York. He served his internship and residency at Columbia-Presbyterian Medical Center in New York, where he participated in the thoracic organ procurement team and was chief resident during his final year of training. Dr. Moazami completed a fellowship in cardiothoracic surgery at Cleveland Clinic in 2001 and continued his post-graduate training with multiple specialty training courses on the leading heart assist devices at institutions across the country.
A dedicated researcher as well as a clinician, Dr. Moazami has been Principal Investigator on nearly two dozen trials of new heart assist devices and other therapies for end-stage heart failure. He has published more than 100 scientific articles in leading peer-reviewed journals, including Circulation, Journal of Heart and Lung Transplantation and Journal of the American College of Cardiology and is a manuscript reviewer for a number of heart and transplantation journals.
Dr. Moazami is a frequent speaker and instructor with more than 150 presentations and educational sessions to his credit. His professional memberships include the International Society for Heart & Lung Transplantation, Society of Thoracic Surgeons. Heart Failure Society of America, American Society for Artificial Internal Organs and American Association for Thoracic Surgery.
Heart surgery, surgical treatment of heart failure, heart transplant, mechanical heart assist devices
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 6/14/2014, Dr. Moazami has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.